Ibrahim Alshaghdali

Dr. Ibrahim Alshaghdali


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
KSKamal (short of Kamaleldin) Said
Kamal (short of Kamaleldin) Said
AAAhmed Alsolami
Ahmed Alsolami
RARuba Mustafa Elsaid Ahmed
Ruba Mustafa Elsaid Ahmed
KAKhalid F Alshammari
Khalid F Alshammari
HAHamad Alshetaiwi
Hamad Alshetaiwi
NANorah Kheder Alharbi
Norah Kheder Alharbi
Background: Timely integrated diagnostic microbiology combines automated identification and antimicrobial susceptibility testing (AST) with assay-specific molecular confirmation. This allows final resistance classifications to be interpreted within one clinical workflow. The novelty of this study is the integration of these complementary diagnostic outputs with organism identity, specimen source, care setting, and available host context across a mixed-pathogen tertiary-care cohort. We characterized the distribution of major clinical priority-pathogen resistance profiles and examined clinical factors associated with high-priority resistances. Methods: This retrospective cross-sectional laboratory-based study included 847 non-duplicate clinical isolates recovered during routine care from a pre-established surveillance cohort at King Salman Specialist tertiary-care hospital in Saudi Arabia from July 2025 to July 2026. Automated organism identification/AST was combined with assay-specific GeneXpert molecular confirmation where applicable. GeneXpert SA Nasal Complete was used for Staphylococcus aureus/MRSA confirmation and Xpert Carba-R for relevant carbapenemase targets; organisms outside these target panels, including Streptococcus pyogenes and Candida spp., were characterized by routine culture and automated identification. Carbapenem resistance was defined by imipenem and/or meropenem resistance and reported as carbapenem-resistant Enterobacterales (CRE) for Klebsiella pneumoniae and Escherichia coli, carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Acinetobacter baumannii (CRAB). Methicillin-resistant Staphylococcus aureus (MRSA) was classified by cefoxitin resistance with concordant GeneXpert confirmation. Exploratory multivariable logistic regression assessed clinical factors associated with CRE and MRSA detection. Results: Gram-negative organisms accounted for 546 isolates (64.5%), Gram-positive organisms accounted for 281 (33.2%), and fungi accounted for 20 (2.4%). Klebsiella pneumoniae was most frequent (176/847; 20.8%), followed by Staphylococcus aureus (169/847; 20.0%) and Escherichia coli (156/847; 18.4%). Priority resistance was highest in Acinetobacter baumannii, with CRAB in 73/74 isolates (98.6%), followed by CRPA in 38/83 P. aeruginosa (45.8%), MRSA in 68/164 S. aureus (41.5%), CRE in 57/176 K. pneumoniae (32.4%), and CRE in 10/156 E. coli (6.4%). In the complete-case CRE model (n = 246; 38 events), K. pneumoniae had higher adjusted odds of CRE than E. coli (aOR 3.91, 95% CI 1.74–9.73; p = 0.002). In the MRSA model (n = 160; 68 events), non-urinary specimens (aOR 3.31, 95% CI 1.21–10.16; p = 0.025) and recorded comorbidity (aOR 3.40, 95% CI 1.26–9.64; p = 0.017) were independently associated with MRSA detection. Conclusions: The integrated diagnostic workflow revealed marked organism-specific differences in resistance, led by a very high CRAB burden and substantial CRPA, MRSA, and K. pneumoniae CRE. Interpreting the final laboratory classification together with organism identity, specimen source, and care setting provides a practical framework for focused diagnostic reporting, antimicrobial stewardship, and infection-control prioritization in tertiary care.

21 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MGMohamed Ahmed Ghaleb
Mohamed Ahmed Ghaleb
OEOmar Elsayed
Omar Elsayed
MEMahmoud F. Elshahat
Mahmoud F. Elshahat
AGahmed goha
ahmed goha
IAIbrahim Alshaghdali
Ibrahim Alshaghdali
NANaif Saad ALGhasab
Naif Saad ALGhasab
Background and Clinical Significance: Left ventricular free-wall rupture (LVFWR) is a rare but devastating mechanical complication of acute myocardial infarction (AMI), with reported in-hospital mortality approaching 90% without surgical intervention. Although its incidence has declined in the contemporary primary percutaneous coronary intervention (PCI) era, LVFWR remains an important cause of early post-infarction death, particularly after delayed reperfusion or fibrinolytic therapy. Subacute or contained “oozing” ruptures pose a unique diagnostic challenge because hemodynamic stability and nonspecific symptoms can mask the underlying catastrophe, and standard transthoracic echocardiography may fail to visualize a sealed defect. Contrast-enhanced cardiac computed tomography (CT) has emerged as a valuable adjunct in this setting, enabling early recognition and surgical planning. Case Presentation: We report a case of a 51-year-old male, a heavy smoker, with acute lateral ST-segment elevation myocardial infarction (STEMI) treated with thrombolysis at a referring hospital, followed by percutaneous coronary intervention (PCI) to the obtuse marginal branch. Despite reperfusion, he developed persistent pleuritic chest pain and a small pericardial effusion. Cardiac computed tomography (CT) demonstrated a contained (sealed) lateral-wall oozing-type left ventricular free-wall rupture (LVFWR) with thrombus sealing the defect. A multidisciplinary heart team initially opted for diligent observation with frequent echocardiography. Within the first 24 h, the pericardial effusion increased, and echocardiography showed circumferential effusion with lateral wall thickening and hematoma, prompting emergent sternotomy. Intraoperatively, a large posterolateral infarct with an oozing-type LV free-wall rupture was identified. Surgical repair was performed using interrupted pledgeted sutures, native pericardial patch, BioGlue, and an overlying Teflon patch, with intra-aortic balloon pump (IABP) support. This case demonstrates the complementary diagnostic value of multimodality imaging—echocardiography for serial monitoring of the pericardial effusion and regional wall changes, and cardiac CT for direct characterization of the contained (sealed) defect—and the timely transition from conservative to surgical management in oozing-type rupture. The patient recovered uneventfully and was discharged in stable condition. Conclusions: This case highlights the diagnostic value of multimodality imaging—particularly cardiac CT—in detecting contained (sealed) LVFWR when echocardiography is inconclusive. Early recognition and prompt surgical intervention enabled a successful outcome in this otherwise frequently fatal complication.